Fundraising Fox

OncoResponse

Houston, US · Founded 2015 · Delaware corporation · 5 known investors

oncoresponseinc.com ↗
Biotech

Founders & leadership

SM
Sean McCarthyDirector
AB
Alice BexonExecutive Officer
SG
Steven GillisDirector
CJ
Clifford J. StocksDirector, Executive Officer
KD
Kamal D. PuriExecutive Officer
CG
Carol GallagherDirector
JM
John McKearnDirector
CR
Chris RussellExecutive Officer
WH
Wende HuttonDirector
RD
Roberto De PontiDirector
RH
Russ HawkinsonExecutive Officer
AG
Alan GinsbergDirector

Investors · 5

3B Future Health FundMonaco · $12Mvia Roberto De Ponti · board
Canaan PartnersStamford · $500K – $20Mvia Wende Hutton · board
GreatPoint VenturesSan Francisco · $250K – $20M
RiverVest Venture PartnersSt. Louis · $500K – $3Mvia John McKearn · board
ARCH Venture PartnersreportedChicago · $50K – $250M

Reported raises · per SEC filings

Form D private placements
▶$6MraisedMay 2025 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sean A. McCarthyDirector
  • Roberto De PontiDirector
  • Alice BexonExecutive Officer
  • Steven GillisDirector
  • Clifford J. StocksDirector, Executive Officer
  • Kamal D. PuriExecutive Officer
  • Carol GallagherDirector
  • John McKearnDirector
  • Chris RussellExecutive Officer
  • Wende HuttonDirector
Amount sold
$6M
First sale
Apr 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$13.9MraisedMay 2023 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roberto DePontiDirector
  • Ted KoutouzisDirector
  • Steven GillisDirector
  • Kamal D. PuriExecutive Officer
  • Sean McCarthyDirector
  • Robert LechleiderExecutive Officer
  • Wende HuttonDirector
  • Christopher A. RussellExecutive Officer
  • Clifford J. StocksExecutive Officer, Director
  • John McKearnDirector
Offering amount
$40M
Amount sold
$13.9M
Proceeds to insiders
$4.8M
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.6MraisedMar 2021 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clifford StocksExecutive Officer, Director
  • Roberto DePontiDirector
  • Steven GillisDirector
  • Wende HuttonDirector
  • Ted KoutouzisDirector
  • John McKearnDirector
  • Patrick Joseph HojloDirector
  • Daguang WangDirector
  • Bob LechleiderExecutive Officer
  • Kamal PuriExecutive Officer
Offering amount
$60M
Amount sold
$40.6M
Proceeds to insiders
$1.4M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19MraisedSep 2018 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clifford StocksExecutive Officer, Director
  • Steven GillisDirector
  • John McKearnDirector
  • Andrew PerlmanDirector
  • Roberto DePontiDirector
  • Wende HuttonDirector
  • Nathan JorgensenDirector
Offering amount
$40M
Amount sold
$19M
Proceeds to insiders
$1.2M
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.5MraisedMar 2017 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clifford StocksExecutive Officer, Director
  • Roberto De PontiDirector
  • Andrew PerlmanDirector
  • Russ HawkinsonExecutive Officer
  • Steve GillisDirector
  • Wende HuttonDirector
  • Alan GinsbergDirector
Offering amount
$34M
Amount sold
$29.5M
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.